EGFR and colon carcinoma: The results of the mechanism study imply that musarin inhibits proliferation of colonic carcinoma cells and the epithelial to mesenchymal transition via altering the selectivity of EGFR phosphorylation and by differentially expressing other related signaling molecules that are connected to this process.